826Health Economic Outcome Analysis of patients randomized in the SECURE Phase III Trial comparing Isavuconazole to Voriconazole for primary treatment of Invasive fungal disease caused by Aspergillus Species or other filamentous Fungi
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.